Related Experiment Video
Updated: Jun 13, 2025

07:11
Constructing Cyclic Peptides Using an On-Tether Sulfonium Center
Published on: September 28, 2022
2.6K
Substrate interactions guide cyclase engineering and lasso peptide diversification
Susanna E Barrett1,2, Song Yin3, Peter Jordan4
1Department of Chemistry, University of Illinois Urbana-Champaign, Urbana, IL, USA.
Nature Chemical Biology
|September 11, 2024
Summary
Researchers modeled how lasso cyclases form unique lasso peptides. Engineering these enzymes enables production of novel variants targeting integrin αvβ8 for cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Lasso peptides are stable molecules with a unique rotaxane conformation.
- The mechanism of ATP-dependent lasso cyclase in forming these peptides is poorly understood due to enzyme instability.
- Understanding this process is key to harnessing lasso peptides for therapeutic applications.
Purpose of the Study:
- To elucidate the mechanism by which lasso cyclases constrain substrate peptides into lasso peptide products.
- To engineer lasso cyclases for novel substrate acceptance and therapeutic applications.
Main Methods:
- Combined substrate tolerance data, structural predictions, and bioinformatic analysis.
- Utilized molecular dynamics simulations and mutational scanning to model enzyme-substrate interactions.
- Rationally engineered diverse lasso cyclases to alter substrate specificity.
Main Results:
- Developed a model for substrate peptide orientation within the lasso cyclase active site.
- Successfully engineered multiple lasso cyclases to accept previously rejected substrates.
- Demonstrated robust production of novel lasso peptide variants with high affinity for integrin αvβ8.
Conclusions:
- The study provides a mechanistic model for lasso cyclase activity.
- Enzyme engineering successfully expanded substrate specificity and created novel therapeutic candidates.
- Engineered lasso cyclases offer a promising platform for developing anti-cancer agents targeting integrin αvβ8.
Related Concept Videos
Assembly of Signaling Complexes
5.7K
Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
5.7K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K

